Regarding MLH1 and MSH2 protein inactivation, the performance of each method (IHC and Pentaplex-PCR) in MMR deficiency identification could not be correctly evaluated because of the low number of cases in each category and a high proportion of cases without genetic investigations. This evidence concerns the gene MSH2 and mismatch repair cancer syndrome 1.